000			03099cam a2200445Mi 4500
001			ocn952070849
005			20240726105024.0
008			151013s2016 nju ob 001 0 eng d
040			_aP@U _beng _epn _erda _cP@U _dNT _dYDXCP _dEBLCP _dJSTOR _dYDX _dOCLCQ _dIDB _dUAB _dUBY _dOCLCQ
020			_a9780813574400 _q((electronic)l(electronic)ctronic)
020			_a9780813574417 _q((electronic)l(electronic)ctronic)
043			_an-us---
050	0	4	_aRA644 _b.S455 2016
100	1		_aMawdsley, Stephen E. _e1
245	1	0	_aSelling science : _bpolio and the promise of gamma globulin / _cStephen E. Mawdsley.
260			_aNew Brunswick, New Jersey : _bRutgers University Press, _c(c)2016.
300			_a1 online resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_adata file _2rda
490	0		_aCritical issues in health and medicine
504			_a2
505	0	0	_aForging momentum -- _tBuilding consent for a clinical trial -- _tMarketing and mobilization -- _tSelling science -- _tOperation marbles and lollipops -- _tThe national experiment.
520	2		_a"In Selling Science : Polio and the Promise of Gamma Globulin, medical historian Stephen E. Mawdsley examines the untold story of the first effort to control polio prior to the development of the Salk vaccine. In the early 1950s, Dr. William McD. Hammon and the National Foundation for Infantile Paralysis launched a pioneering medical experiment on a previously untried scale. Conducted on over 55,000 healthy children in Texas, Utah, Iowa, and Nebraska, this landmark study attempted to assess the safety and effectiveness of a blood component, 'gamma globulin' (which is derived by a process known as 'fractionation') to prevent paralytic polio. Although the study was condemned by many prominent health professionals, harbored potential risks, and returned dubious results, it was perceived as a triumph and used to justify a national immunization program from 1953 to 1954"--Provided by publisher.
530			_a2 _ub
600	1	0	_aHammon, William McD. _q(William McDowell), _d1904-1989.
610	2	0	_aNational Foundation for Infantile Paralysis _xHistory.
650		0	_aScience _xEconomic aspects _xHistory _y20th century.
650		0	_aScience _xSocial aspects _xHistory _y20th century.
650		0	_aClinical trials _zUnited States _xHistory _y20th century.
650		0	_aChildren _xDiseases _zUnited States _xPrevention _xHistory _y20th century.
650		0	_aGamma globulins _xResearch _zUnited States _xHistory _y20th century.
650		0	_aPoliomyelitis _xResearch _zUnited States _xHistory _y20th century.
650		0	_aPoliomyelitis _zUnited States _xPrevention _xHistory _y20th century.
655		1	_aElectronic Books.
856	4	0	_uhttps://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=1257351&site=eds-live&custid=s3260518 _zClick to access digital title | log in using your CIU ID number and my.ciu.edu password
942			_cOB _D _eEB _hRA. _m2016 _QOL _R _x _8NFIC _2LOC
999			_c86350 _d86350
902			_a1 _bCynthia Snell _c1 _dCynthia Snell